This meeting will highlight recent advances in modeling cancer using mouse models, cell lines, organoids, PDX models, and computational models, focusing on their impact for advancing our understanding of cancer biology, prevention and treatment, and drug response and resistance.
This EACR-AACR-ASPIC conference on Tumor Microenvironment (TME) will bring together thought leaders spanning the breadth of TME, immune-oncology, computational biology and biomedical technology disciplines to discuss novel approaches to identify critical mechanisms regulating the crosstalk in these tumor ecosystems.
The aim of this AACR Special Conference is to move away from the simplistic view of cancer evolution as a merely genetic phenomenon and to discuss instead how microenvironmental, immune cell, genetic and epigenetic heterogeneity interact and evolve and how this influences cancer progression and therapy success or failure.
The Cancer, Autoimmunity, and Immunology Conference was created to delve into understanding the biology of immune-related adverse events that have occurred in cancer patients treated with immunotherapies.
Organized in partnership with the National Cancer Institute Center for Global Health; the American Society of Clinical Oncology; the Consortium of Universities for Global Health (CUGH); Georgetown Lombardi Comprehensive Cancer Center; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; and the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center.